Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Owen Scott Muir · Said 27 May 2026 · owen-2253

Quote

Not a forecast

“The FDA thinks it works. I have a lot of respect for FDA officers, especially at CDRH (that is the center for devices and radiologic health, the “device” side of the house). I will thus think it works in PTSD.”
· A New At-Home PTSD Treatment is FDA-Approved! · substack post

Author's provisional stance on the efficacy of Neurovalens Modius Spero (VeNS) for PTSD: he defers to FDA CDRH judgment and adopts the view that the device works in PTSD, pending publication of the 383-adult active-vs-sham trial NCT05242367 (completed Dec 2024, no results posted).

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements